98 related articles for article (PubMed ID: 17339443)
1. Differential survival of cytotoxic T cells and memory cell precursors.
Zhang M; Byrne S; Liu N; Wang Y; Oxenius A; Ashton-Rickardt PG
J Immunol; 2007 Mar; 178(6):3483-91. PubMed ID: 17339443
[TBL] [Abstract][Full Text] [Related]
2. A role for the granzyme B inhibitor serine protease inhibitor 6 in CD8+ memory cell homeostasis.
Phillips T; Opferman JT; Shah R; Liu N; Froelich CJ; Ashton-Rickardt PG
J Immunol; 2004 Sep; 173(6):3801-9. PubMed ID: 15356127
[TBL] [Abstract][Full Text] [Related]
3. Serpinb9 (Spi6)-deficient mice are impaired in dendritic cell-mediated antigen cross-presentation.
Rizzitelli A; Meuter S; Vega Ramos J; Bird CH; Mintern JD; Mangan MS; Villadangos J; Bird PI
Immunol Cell Biol; 2012 Oct; 90(9):841-51. PubMed ID: 22801574
[TBL] [Abstract][Full Text] [Related]
4. Serine protease inhibitor-6 differentially affects the survival of effector and memory alloreactive CD8-T cells.
Azzi J; Ohori S; Ting C; Uehara M; Abdoli R; Smith BD; Safa K; Solhjou Z; Lukyanchykov P; Patel J; McGrath M; Abdi R
Am J Transplant; 2015 Jan; 15(1):234-41. PubMed ID: 25534448
[TBL] [Abstract][Full Text] [Related]
5. Serine protease inhibitor 6 plays a critical role in protecting murine granzyme B-producing regulatory T cells.
Azzi J; Skartsis N; Mounayar M; Magee CN; Batal I; Ting C; Moore R; Riella LV; Ohori S; Abdoli R; Smith B; Fiorina P; Heathcote D; Bakhos T; Ashton-Rickardt PG; Abdi R
J Immunol; 2013 Sep; 191(5):2319-27. PubMed ID: 23913965
[TBL] [Abstract][Full Text] [Related]
6. Serine protease inhibitor 6 is required to protect dendritic cells from the kiss of death.
Lovo E; Zhang M; Wang L; Ashton-Rickardt PG
J Immunol; 2012 Feb; 188(3):1057-63. PubMed ID: 22227570
[TBL] [Abstract][Full Text] [Related]
7. Serine protease inhibitor 6 protects cytotoxic T cells from self-inflicted injury by ensuring the integrity of cytotoxic granules.
Zhang M; Park SM; Wang Y; Shah R; Liu N; Murmann AE; Wang CR; Peter ME; Ashton-Rickardt PG
Immunity; 2006 Apr; 24(4):451-61. PubMed ID: 16618603
[TBL] [Abstract][Full Text] [Related]
8. Spi6 protects alloreactive CD4(+) but not CD8 (+) memory T cell from granzyme B attack by double-negative T regulatory cell.
Su Y; Jevnikar AM; Huang X; Lian D; Zhang Z-
Am J Transplant; 2014 Mar; 14(3):580-93. PubMed ID: 24730048
[TBL] [Abstract][Full Text] [Related]
9. Serine protease inhibitor 6 protects iNKT cells from self-inflicted damage.
Ansari AW; Temblay JN; Alyahya SH; Ashton-Rickardt PG
J Immunol; 2010 Jul; 185(2):877-83. PubMed ID: 20543105
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin B controls the persistence of memory CD8+ T lymphocytes.
Byrne SM; Aucher A; Alyahya S; Elder M; Olson ST; Davis DM; Ashton-Rickardt PG
J Immunol; 2012 Aug; 189(3):1133-43. PubMed ID: 22745374
[TBL] [Abstract][Full Text] [Related]
11. Serine protease inhibitor 2A is a protective factor for memory T cell development.
Liu N; Phillips T; Zhang M; Wang Y; Opferman JT; Shah R; Ashton-Rickardt PG
Nat Immunol; 2004 Sep; 5(9):919-26. PubMed ID: 15311278
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells express serine protease inhibitor to evade the host immune response.
El Haddad N; Heathcote D; Moore R; Yang S; Azzi J; Mfarrej B; Atkinson M; Sayegh MH; Lee JS; Ashton-Rickardt PG; Abdi R
Blood; 2011 Jan; 117(4):1176-83. PubMed ID: 21076046
[TBL] [Abstract][Full Text] [Related]
13. SPI-CI and SPI-6 cooperate in the protection from effector cell-mediated cytotoxicity.
Bots M; Kolfschoten IG; Bres SA; Rademaker MT; de Roo GM; Krüse M; Franken KL; Hahne M; Froelich CJ; Melief CJ; Offringa R; Medema JP
Blood; 2005 Feb; 105(3):1153-61. PubMed ID: 15454490
[TBL] [Abstract][Full Text] [Related]
14. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
[TBL] [Abstract][Full Text] [Related]
15. Induction of cytotoxic granules in human memory CD8+ T cell subsets requires cell cycle progression.
Meng Y; Harlin H; O'Keefe JP; Gajewski TF
J Immunol; 2006 Aug; 177(3):1981-7. PubMed ID: 16849512
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood.
Bratke K; Kuepper M; Bade B; Virchow JC; Luttmann W
Eur J Immunol; 2005 Sep; 35(9):2608-16. PubMed ID: 16106370
[TBL] [Abstract][Full Text] [Related]
17. Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules.
Takata H; Takiguchi M
J Immunol; 2006 Oct; 177(7):4330-40. PubMed ID: 16982867
[TBL] [Abstract][Full Text] [Related]
18. A critical role for granzyme B, in addition to perforin and TNFalpha, in alloreactive CTL-induced mouse pancreatic beta cell death.
Sutton VR; Estella E; Li C; Chen M; Thomas HE; Kay TW; Trapani JA
Transplantation; 2006 Jan; 81(2):146-54. PubMed ID: 16436955
[TBL] [Abstract][Full Text] [Related]
19. The role for monocyte chemoattractant protein-1 in the generation and function of memory CD8+ T cells.
Wang T; Dai H; Wan N; Moore Y; Dai Z
J Immunol; 2008 Mar; 180(5):2886-93. PubMed ID: 18292510
[TBL] [Abstract][Full Text] [Related]
20. The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency.
Hirst CE; Buzza MS; Bird CH; Warren HS; Cameron PU; Zhang M; Ashton-Rickardt PG; Bird PI
J Immunol; 2003 Jan; 170(2):805-15. PubMed ID: 12517944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
